Rani Therapeutics Holdings Inc reports results for the quarter ended September 30 - Earnings Summary

Rani Therapeutics Holdings

15/11/2024 22:06

* Rani Therapeutics Holdings Inc  RANI.OQ  reported a
quarterly
adjusted loss of 24 cents​​ per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of -36 cents.  The mean expectation of
nine analysts for the quarter was for a loss of 26 cents per
share. Wall Street expected results to range from -44 cents
to -12 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Rani Therapeutics Holdings Inc's reported EPS for the
quarter
was a loss of 24 cents​.
    * The company reported a quarterly loss of $6.78 million.
    * Rani Therapeutics Holdings Inc shares had risen by 8.8%
this
quarter and lost 29.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Rani Therapeutics
Holdings Inc is 10.50 
This summary was machine generated from LSEG data November 15 at
10:06 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.26          -0.24          Beat
 Jun. 30 2024      -0.32          -0.26          Beat
 Mar. 31 2024      -0.20          -0.29          Missed
 Dec. 31 2023      -0.31          -0.27          Beat